Interleukin-2 in bone marrow transplantation.
Verma
U N
UN
Georgetown University School of Medicine, Department of Medical Oncology, Washington, DC 20007-2197, USA.
Charak
B S
BS
Rajagopal
C
C
Mazumder
A
A
D000818:Animals; D016026:Bone Marrow Transplantation / Q000276:immunology*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D006410:Hematopoiesis; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use* / Q000633:toxicity; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology / Q000637:transplantation*; D009369:Neoplasms / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology; D014182:Transplantation, Autologous
D007376:Interleukin-2